Understanding the difficulties of drug importation.
As we move into the new year, one of the most talked-about topics in healthcare is also one of the most complex: rising prescription drug prices. One of the most intriguing ideas on how to tackle this problem is also, on its face, one of the simplest solutions: authorizing states to import commonly used drugs from Canada, where the government controls prices as a method of consumer protection. President Biden has signaled his support, but as with many things in healthcare, it’s not as simple as it might seem.
Just last month, Colorado became the latest state looking to get permission from the federal government to import medicine from Canada, a process that was delineated in a U.S. Department of Health and Human Services (HHS) final rule passed in 2020. Colorado’s efforts started with a bill passed back in 2019 that required the Colorado Department of Health Care Policy & Financing to develop a prescription drug importation program and attempt to get federal approval. In the process of developing this importation program, the Department analyzed current prescription drug market dynamics, including the role of pharmacy benefit managers (PBMs) and the framework of Canadian drug pricing, met with relevant stakeholders in Colorado and Canada, and worked to identify potential supply-chain partners for the importation scheme.
In their written proposal for federal approval, the Department estimated a 65-percent reduction in costs by importing prescription drugs from Canada: somewhere between $53 million and $88 million annually. It listed 112 drugs that are either high-cost or high-volume in the state, which include medicines that treat common conditions such as high blood pressure, asthma, Type 2 diabetes, and women’s health issues. The proposal described the route these drugs would take from the manufacturer to pharmacies in Colorado, including entry into the U.S. through the border crossing in Buffalo, New York, and details the testing process that would be conducted to authenticate and ensure quality of the drugs.
The results of those tests will be sent to the Food and Drug Administration (FDA) for review and approval, after which they will be distributed to contracted pharmacies for dispensing. This means that all consumers, carriers, hospitals, and doctors in the state will have access to these drugs, as long as they use specified pharmacies, which Colorado hopes will include community and mail-based pharmacies to expand access.
Despite a well-developed plan, the biggest issue facing Colorado (as well as Florida, New Hampshire, and New Mexico before it) is that no state’s application has been approved under the rule yet. The rule itself does not provide any details regarding a timeline or review process for federal approval of these applications. And while President Biden has encouraged the idea, HHS Secretary Xavier Becerra would not speak on whether any application would be approved in 2023, when recently asked. While New Hampshire’s proposal was denied for lacking a Canadian wholesaler, Florida is currently suing the Biden Administration under the Administrative Procedure Act for allegedly dragging its feet on approving their application.
Additionally, there are several potential roadblocks from other parties involved. Some Canadian stakeholders have suggested that shipping prescription drugs to the U.S. could result in more frequent drug shortages in their country. Pharmacies have expressed concerns that agreeing to participate in this importation program could negatively affect current wholesale contracts they have. Drug manufacturers would likely need to renegotiate contracts with wholesalers for this program, and many expressed no desire to do so. Many in the drug industry have expressed concerns about safety.
While many are in agreement about the concept of importing prescription drugs safely from Canada, the reality is a bit more nuanced. What is certain is that it is certainly not a magic pill to tackle rising prices in the industry, and this idea will likely be just one tool in the toolkit for states as they return to legislative sessions in the coming months.
Here are my thoughts on what to expect when the federal shutdown finally ends. First, the lights don’t all flick back on at once. Agencies
Back in June, I was on the Monitor Mondays broadcast discussing the initial momentum within the Trump Administration for a single, national provider directory. Now,
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
